November 05, 2019
Rose
Manufacturers say the current shortage is among the worst they have experienced since the popular, wide-ranging treatment came to market. In other pharmaceutical news: Sen. Bill Cassidy (R-La.) touts value-based payments for cutting drug costs; a new approach to gene therapy offers tentative hope; a controversy arises over a pre-term birth medication; and more.
from Kaiser Health News https://ift.tt/2oORPx3
November 05, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Fuzzy Math Fuels Sanders’ Claim That Cost Barriers To Health Care Kill 30,000 A Year- Oregon Has Botched Efforts To Move Patients Out Of Restrictive Psychiatric Facilities, Investigation Finds
- New Budget Boosts Health Coverage For Low-Income Californians
- Cerner System Malfunction Leads To Two-Hour Outage Of Medical Records At Dozens Of Hospitals
- Viewpoints: Pros And Cons Of All Those Health Care Jobs; Organ Donation Process Is Making Progress, But Still Too Many Lives Are Lost
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment